US Bancorp’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-830
| Closed | -$263K | – | 4108 |
|
|
2023
Q4 | $263K | Buy |
830
+169
| +26% | +$53.5K | ﹤0.01% | 1871 |
|
|
2023
Q3 | $112K | Sell |
661
-2,044
| -76% | -$346K | ﹤0.01% | 2095 |
|
|
2023
Q2 | $587K | Sell |
2,705
-194
| -7% | -$42.1K | ﹤0.01% | 1302 |
|
|
2023
Q1 | $527K | Sell |
2,899
-705
| -20% | -$128K | ﹤0.01% | 1378 |
|
|
2022
Q4 | $708K | Buy |
3,604
+19
| +0.5% | +$3.73K | ﹤0.01% | 1226 |
|
|
2022
Q3 | $807K | Sell |
3,585
-797
| -18% | -$179K | ﹤0.01% | 1152 |
|
|
2022
Q2 | $554K | Buy |
4,382
+3,762
| +607% | +$476K | ﹤0.01% | 1384 |
|
|
2022
Q1 | $79K | Buy |
620
+40
| +7% | +$5.1K | ﹤0.01% | 2387 |
|
|
2021
Q4 | $76K | Hold |
580
| – | – | ﹤0.01% | 2429 |
|
|
2021
Q3 | $71K | Sell |
580
-205
| -26% | -$25.1K | ﹤0.01% | 2465 |
|
|
2021
Q2 | $90K | Sell |
785
-1,580
| -67% | -$181K | ﹤0.01% | 2368 |
|
|
2021
Q1 | $284K | Sell |
2,365
-1,756
| -43% | -$211K | ﹤0.01% | 1769 |
|
|
2020
Q4 | $419K | Sell |
4,121
-1,375
| -25% | -$140K | ﹤0.01% | 1533 |
|
|
2020
Q3 | $425K | Buy |
5,496
+4,198
| +323% | +$325K | ﹤0.01% | 1410 |
|
|
2020
Q2 | $145K | Buy |
1,298
+249
| +24% | +$27.8K | ﹤0.01% | 1913 |
|
|
2020
Q1 | $76K | Buy |
1,049
+664
| +172% | +$48.1K | ﹤0.01% | 2117 |
|
|
2019
Q4 | $29K | Buy |
+385
| New | +$29K | ﹤0.01% | 2715 |
|